TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:
Spire Healthcare Group plc
2. Reason for the notification (please state Yes/No):
An acquisition or disposal of voting rights: YES
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached:
An event changing the breakdown of voting rights: ( )
Other (please specify):
3. Full name of person(s) subject to the notification obligation:
remgro limited
4. Full name of shareholder(s) (if different from 3.):
REMGRO JERSEY LIMITED
5. Date of the transaction (and date on which the threshold is crossed or reached if different): 24 August 2015
6. Date on which issuer notified: 25 August 2015
7. Threshold(s) that is/are crossed or reached:
Prior to transaction: 29.9% Subsequent to transaction below 3%
8. Notified details: |
|||||||
A: Voting rights attached to shares viii, ix |
|||||||
Class/type of
|
Situation previous |
Resulting situation after the triggering transaction |
|||||
Number |
Number |
Number |
Number of voting |
% of voting rights x |
|||
Direct |
Direct xi |
Indirect xii |
Direct |
Indirect |
|||
ORDINARY
|
119,923,335 |
119,923,335 |
|
|
0 |
|
0
|
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument |
Expiration Date |
Exercise/Conversion Period/ Date |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
% of voting rights |
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument |
Exercise price |
Expiration date |
Exercise/Conversion period |
Number of voting rights instrument refers to |
% of voting rights |
|
Nominal |
Delta |
|||
|
|
|
Total (A+B+C)
|
|
Number of voting rights |
% of voting rights |
0 |
0% |
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
1. REMGRO LIMITED (ULTIMATE PARENT): INDIRECT HOLDING OF 29.9% OF VOTING RIGHTS IN ISSUER
2. REMGRO HEALTHCARE HOLDINGS (PTY) LTD [CURRENTLY KNOWN AS FRIEDSHELF 1670, IN PROCESS OF BEING RENAMED] (WHOLLY OWNED SUBSIDIARY OF REMGRO LIMITED): INDIRECT HOLDING OF 29.9% OF VOTING RIGHTS IN ISSUER
3. BUSINESS VENTURE INVESTMENTS NO 1871 (PTY) LTD (WHOLLY OWNED SUBSIDIARY OF REMGRO HEALTHCARE HOLDINGS (PTY) LTD): INDIRECT HOLDING OF 29.9% OF VOTING RIGHTS IN ISSUER
4. REMGRO JERSEY LIMITED (WHOLLY OWNED SUBSIDIARY OF BUSINESS VENTURE INVESTMENTS NO 1871 (PTY) LTD): DIRECT HOLDING OF 29.9% OF VOTING RIGHTS IN ISSUER
Please note that it is only the interests of parties 1 and 2 which have changed. The interests of parties 3 and 4 remain unchanged.
Proxy Voting:
10. Name of the proxy holder: N/A
11. Number of voting rights proxy holder will cease to hold: N/A
12. Date on which proxy holder will cease to hold voting rights: N/A
13. Additional information:
14. Contact name:
Anthony Dand, Interim Deputy Secretary, Spire Healthcare Group plc
15. Contact telephone number:
+ 44 (0)20 7427 9092